Genetically Distinct Subsets within ANCA-Associated Vasculitis
By P. Lyons, Tim F. Rayner, Sapna Trivedi, J. Holle, R. Watts, D. Jayne, B. Baslund, P. Brenchley, A. Bruchfeld, A. Chaudhry and 27 more. New England Journal of Medicine, 2012
933 citations recorded by the source corpus.
BACKGROUND Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener’s granulomatosis) and microscopic polyangiitis. Its cause is unknown, and there is debate about whether it is a single disease entity and what role ANCA plays in its pathogenesis. We investigated its genetic basis. METHODS A genomewide association study was performed in a discovery cohort of 1233 U.K. patients with ANCA-associated vasculitis and 5884 controls and was replicated in 1454 Northern European case patients and 1666 controls. Quality control, population stratification, and statistical analyses were performed according to standard criteria. RESULTS We found both major-histocompatibility-complex (MHC) and non-MHC associations with ANCA-associated vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct. The strongest genetic associations were with the antigenic specificity of ANCA, not with the clinical syndrome. Anti–proteinase 3 ANCA was associated with HLA-DP and the genes encoding α1-antitrypsin (SERPINA1) and proteinase 3 (PRTN3) (P = 6.2×10−89, P = 5.6×10−12, and P = 2.6×10−7, respectively). Anti–myeloperoxidase ANCA was associated with HLA-DQ (P = 2.1×10−8). CONCLUSIONS This study confirms that the pathogenesis of ANCA-associated vasculitis has a genetic component, shows genetic distinctions between granulomatosis with polyangiitis and microscopic polyangiitis that are associated with ANCA specificity, and suggests that the response against the autoantigen proteinase 3 is a central pathogenic feature of proteinase 3 ANCA–associated vasculitis. These data provide preliminary support for the concept that proteinase 3 ANCA–associated vasculitis and myeloperoxidase ANCA–associated vasculitis are distinct autoimmune syndromes. (Funded by the British Heart Foundation and others.)
Subfields: Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Rheumatology
View Paper: https://www.semanticscholar.org/paper/cdeee86f1a62d2669f94f942bc63a1bea6bb275a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Yates
- R. Watts
- J. Holle
- V. Tesar
- C. Mukhtyar
- N. Yalçındağ
- J. Mills
- J. Mooney
Citations in the corpus
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (2016, background): “Indeed, the current status quo of classification systems has been called into question by the findings of a recent genome-wide association study, which has provided evidence for possible genetic differences between GPA and MPA which segregate along ANCA specificity lines (46).”